Taken together, their tissue and cell expression pattern, microbial recognition properties and ability to modulate lymphocyte activation/differentiation and cell adhesion provide the basis for considering both CD5 and CD6 as contributors to IBD pathogenesis. This evidence concerns the gene CD5 and inflammatory bowel disease.